Phase II Randomized Study: Whole Brain Radiotherapy and Concomitant Temozolomide, Compared With Whole Brain Radiotherapy for Brain Metastases Treatment.

Trial Profile

Phase II Randomized Study: Whole Brain Radiotherapy and Concomitant Temozolomide, Compared With Whole Brain Radiotherapy for Brain Metastases Treatment.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 May 2013

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Brain metastases; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2010 Results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
    • 24 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top